Haruka Shinohara 篠原悠

Researcher Number	10787047
Affiliation (based on the past Project Information) *help	2019 – 2022: 国立研究開発法人国立がん研究センター, 研究所, 特任研究員 2018: 岐阜大学, 大学院連合創薬医療情報研究科, 研究員
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords	Principal Investigator 標的分子同定 / エネルギー代謝 / 薬剤耐性 / 中鎖脂肪酸 / 慢性骨髄性白血病 / 創薬 / 急性骨髄性白血病 / 耐性 / オートファジー / ドラッグデリバリーシステム

中鎖脂肪酸結合分子の機能解析と薬剤耐性白血病への治療応用Principal Investigator
- Principal Investigator
  
  篠原悠
- Project Period (FY)
  2021 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  National Cancer Center Japan
Breakthrough for overcoming drug resistance in chronic myeloid leukemia by medium-chain fatty-acid derivativesPrincipal Investigator
- Principal Investigator
  
  Haruka Shinohara
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  National Cancer Center Japan
  Gifu University

All 2021 2019 2018

All Journal Article Presentation

[Journal Article] STAMP inhibitor Asciminib and medium-chain fatty-acid derivative AIC-47: novel therapies for chronic myeloid leukemia2021
- Author(s)
  Uchiyama Satoshi、Shinohara Haruka、Chi SungGi、Tabata Rikako、Guo Yong-Mei、Yuda Junichiro、Ono Takaaki、Minami Yosuke
- Journal Title
  
  Hematology and Medical Oncology
  
  Volume: 6 Issue: 3 Pages: 1-5
- DOI
  10.15761/hmo.1000233
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K15585
[Journal Article] MicroRNA-143/Musashi-2/KRAS cascade contributes positively to carcinogenesis in human bladder cancer.2019
- Author(s)
  Tsujino T,Sugito N, Taniguchi K, Honda R, Komura K, Yoshikawa Y, Takai T, Minami K, Kuranaga Y, Shinohara H, Tokumaru Y, Heishima K, Inamoto T, Azuma H, Akao Y.
- Journal Title
  
  Cancer Sci.
  
  Volume: 110(7) Issue: 7 Pages: 2189-9
- DOI
  10.1111/cas.14035
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K11033, KAKENHI-PROJECT-18K15273, KAKENHI-PROJECT-19K18624, KAKENHI-PROJECT-17K11164
[Journal Article] Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase2019
- Author(s)
  Tokumaru Yoshihisa、Tajirika Toshihiro、Sugito Nobuhiko、Kuranaga Yuki、Shinohara Haruka、Tsujino Takuya、Matsuhashi Nobuhisa、Futamura Manabu、Akao Yukihiro、Yoshida Kazuhiro
- Journal Title
  
  International Journal of Molecular Sciences
  
  Volume: 20 Issue: 7 Pages: 1697-1697
- DOI
  10.3390/ijms20071697
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K15273, KAKENHI-PROJECT-17H04280
[Journal Article] Autophagic degradation determines the fate of T315I-mutated BCR-ABL protein.2019
- Author(s)
  Shinohara H, Minami Y, Naoe T, Akao Y.
- Journal Title
  
  Haematologica.
  
  Volume: 未定 Issue: 5 Pages: e191-e194
- DOI
  10.3324/haematol.2018.194431
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K15273
[Presentation] Potent antiproliferative effect of fatty-acid derivative on BCR-ABL-mutated leukemia.2019
- Author(s)
  Haruka Shinohara, Yosuke Minami, Tomoki Naoe, Issay Kitabayashi, Yukihiro Akao
- Organizer
  第78回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K15273
[Presentation] イマチニブ耐性慢性骨髄性白血病に対する中鎖脂肪酸誘導体AIC-47の抗がん作用2018
- Author(s)
  篠原悠、杉戸信彦、倉永祐希、南陽介、直江知樹、赤尾幸博
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K15273
[Presentation] Potent Anti-proliferative Effect of Fatty-acid Derivative AIC-47 on Ph-positive Leukemia2018
- Author(s)
  篠原悠、南陽介、直江知樹、赤尾幸博
- Organizer
  The 9th JSH International Symposium
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K15273

1. INAMOTO Teruo

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
2. 東治人

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Haruka Shinohara 篠原 悠

Research Projects

Research Products

Co-Researchers

中鎖脂肪酸結合分子の機能解析と薬剤耐性白血病への治療応用Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Breakthrough for overcoming drug resistance in chronic myeloid leukemia by medium-chain fatty-acid derivativesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] STAMP inhibitor Asciminib and medium-chain fatty-acid derivative AIC-47: novel therapies for chronic myeloid leukemia2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] MicroRNA-143/Musashi-2/KRAS cascade contributes positively to carcinogenesis in human bladder cancer.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Autophagic degradation determines the fate of T315I-mutated BCR-ABL protein.2019

Author(s)

Journal Title

DOI

Data Source

[Presentation] Potent antiproliferative effect of fatty-acid derivative on BCR-ABL-mutated leukemia.2019

Author(s)

Organizer

Data Source

[Presentation] イマチニブ耐性慢性骨髄性白血病に対する中鎖脂肪酸誘導体AIC-47の抗がん作用2018

Author(s)

Organizer

Data Source

[Presentation] Potent Anti-proliferative Effect of Fatty-acid Derivative AIC-47 on Ph-positive Leukemia2018

Author(s)

Organizer

Data Source

Haruka Shinohara 篠原悠